Table 3.

Treatment groups for studying in vivo release profile of insulin.

Group number	Treatment	Insulin dose (IU/kg)	Frequency of administration
I	Healthy control	-	-
II	Diabetic control	-	-
III	Free insulin solution	0.5 IU/kg	Single
IV	Glargine	0.5 IU/kg/day	Repeated every 24 h
V	Free insulin in thermosensitive copolymer solution	45 IU/kg	Single
VI	CSO-Zinc insulin complexes in thermosensitive copolymer solution	45 IU/kg	Single
VII	Oleic acid-g-CSO zinc insulin complexes in thermosensitive copolymer solution	45 IU/kg	Single